Daphne Zohar, PureTech CEO
Boston-based PureTech Health plc has launched a Scientific Advisory Board (SAB) of distinguished scientists and physicians, and the expansion of PureTech’s senior team.
In a press release on Monday, the company said that, in addition to the over 50 scientists and clinicians in PureTech’s advisory network, the SAB will work closely with PureTech’s Board and executive team to identify new areas of focus and to prioritize themes and new company concepts.
The SAB is chaired by H. Robert Horvitz, Ph.D., PureTech Board Advisor, Nobel Laureate and David H. Koch Professor at the Massachusetts Institute of Technology (MIT). Its initial members include:
- Dennis A. Ausiello, M.D., Chief Emeritus of Medicine at Massachusetts General Hospital and Jackson Distinguished Professor of Clinical Medicine at Harvard Medical School;
- James J. Collins, Ph.D., Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT;
- Sanjiv Sam Gambhir, M.D., Ph.D., Ludwig Professor and Chair, Department of Radiology and Director of the Molecular Imaging Program at Stanford University;
- Raju Kucherlapati, Ph.D., PureTech Board member, Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School; and
- Robert Langer, Sc.D., PureTech Co-founder and Board member, David H. Koch Institute Professor at MIT.
Additional background on each member is found here.
Additionally, PureTech named Harry L. Leider, M.D., Chief Medical Officer of Walgreens Co., as a Senior Advisor to the Company.
Expanding senior team
PureTech is also expanding its senior team with the addition of Joseph B. Bolen Ph.D., who has been appointed Entrepreneur-In-Residence (“EIR”).
Dr. Bolen is the former President of Research and Development at Moderna Therapeutics and former Chief Scientific Officer at Millennium Pharmaceuticals. Additionally, the Company appointed Vincent Hennemand, former Principal in Sanofi’s corporate R&D venture group, as Vice President of Company Development and Operations.
“The Scientific Advisory Board members, all leaders in their respective fields, share PureTech’s vision of addressing major healthcare problems in unexpected ways,” said Daphne Zohar, Chief Executive Officer of PureTech.
“The distinguished members of our Scientific Advisory Board will work closely with PureTech’s world-class scientific and clinical advisory network and our team. We are excited to launch this SAB and to welcome our new advisors and senior team members.”